H.R. 727 would expand the existing federal ban on selling human fetal tissue by broadening what counts as "valuable consideration" in such transactions. Currently, federal law prohibits the sale of fetal tissue but allows payments for certain costs like transportation and storage. This bill would eliminate those exceptions by defining "valuable consideration" to include any payment, gift, waived fees, forgiven debts, reduced charges, or services related to fetal tissue handling—including transportation, processing, preservation, and storage. The legislation would effectively tighten restrictions on payments associated with fetal tissue, affecting research institutions, medical facilities, and organizations involved in tissue procurement and research. The bill has no specific funding mechanisms or implementation timeline mentioned in the text provided.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.